80 FR 60149 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Initial review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 192 (October 5, 2015)

Page Range		60149-60149
FR Document		2015-25274

Federal Register, Volume 80 Issue 192 (Monday, October 5, 2015)

[Federal Register Volume 80, Number 192 (Monday, October 5, 2015)]
[Notices]
[Page 60149]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-25274]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Initial review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
PS16-001, Minority HIV/AIDS Research Initiative (MARI) to Build HIV 
Prevention Treatment and Research Capacity in Disproportionately 
Affected Black and Hispanic Communities and Among Historically 
Underrepresented Researchers.

DATES: 10:00 a.m.-5:00 p.m., December 9-10, 2015 (Closed).

ADDRESSES: Teleconference.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), CDC, 1600 Clifton Road 
NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.

SUPPLEMENTARY INFORMATION: 
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Minority HIV/AIDS Research Initiative (MARI) to Build HIV 
Prevention Treatment and Research Capacity in Disproportionately 
Affected Black and Hispanic Communities and Among Historically 
Underrepresented Researchers'', FOA PS16-001.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-25274 Filed 10-2-15; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 80, No. 192 / Monday, October 5, 2015 / Notices 60149

ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per
Type of respondent Form name responses per
respondents response
respondent (in hours)

Safety and Health Managers .......................... Occupational Safety and Health Program 4,404 1 20/60
Survey.
Informed Consent Form ................................. 4,404 1 2/60
Non Responder Interview .............................. 792 1 5/60

Leroy A. Richardson, applications received in response to under the law, CDC has finalized the
Chief, Information Collection Review Office, ‘‘Minority HIV/AIDS Research Initiative materials. Copies of the final vaccine
Office of Scientific Integrity, Office of the (MARI) to Build HIV Prevention information materials for inactivated
Associate Director for Science, Office of the Treatment and Research Capacity in and live attenuated influenza vaccines
Director, Centers for Disease Control and Disproportionately Affected Black and are available to download from http://
Prevention.
Hispanic Communities and Among www.cdc.gov/vaccines/hcp/vis/
[FR Doc. 2015–25194 Filed 10–2–15; 8:45 am] index.html or http://
Historically Underrepresented
BILLING CODE 4163–18–P Researchers’’, FOA PS16–001. www.regulations.gov (see Docket
The Director, Management Analysis Number CDC–2015–0016).
and Services Office, has been delegated DATES: Beginning no later than March 1,
DEPARTMENT OF HEALTH AND
the authority to sign Federal Register 2016, each health care provider who
HUMAN SERVICES
notices pertaining to announcements of administers any seasonal influenza
Centers for Disease Control and meetings and other committee vaccine to any child or adult in the
Prevention management activities, for both the United States shall provide copies of the
Centers for Disease Control and relevant revised vaccine information
Disease, Disability, and Injury Prevention and the Agency for Toxic materials contained in this notice, in
Prevention and Control Special Substances and Disease Registry. conformance with the August 7, 2015
Emphasis Panel: Initial review CDC Instructions for the Use of Vaccine
Catherine Ramadei,
Information Statements prior to
In accordance with Section 10(a)(2) of Acting Director, Management Analysis and providing such vaccinations. These
the Federal Advisory Committee Act Services Office, Centers for Disease Control
revised vaccine information materials
(Pub. L. 92–463), the Centers for Disease and Prevention.
may also be used earlier than that date.
Control and Prevention (CDC) [FR Doc. 2015–25274 Filed 10–2–15; 8:45 am]
Prior to March 1, 2016, the previous
announces a meeting for the initial BILLING CODE 4163–18–P
edition of these two VISs can be used.
review of applications in response to
FOR FURTHER INFORMATION CONTACT:
Funding Opportunity Announcement
DEPARTMENT OF HEALTH AND Suzanne Johnson-DeLeon (msj1@
(FOA) PS16–001, Minority HIV/AIDS
HUMAN SERVICES cdc.gov), National Center for
Research Initiative (MARI) to Build HIV
Immunization and Respiratory Diseases,
Prevention Treatment and Research
Centers for Disease Control and Centers for Disease Control and
Capacity in Disproportionately Affected
Prevention Prevention, Mailstop A–19, 1600 Clifton
Black and Hispanic Communities and
Road, NE., Atlanta, Georgia 30329.
Among Historically Underrepresented [Docket No. CDC–2015–0016]
SUPPLEMENTARY INFORMATION: The
Researchers.
Final Revised Vaccine Information National Childhood Vaccine Injury Act
DATES: 10:00 a.m.–5:00 p.m., December of 1986 (Pub. L. 99–660), as amended by
9–10, 2015 (Closed). Materials for Seasonal Influenza
Vaccines section 708 of Public Law 103–183,
ADDRESSES: Teleconference. added section 2126 to the Public Health
FOR FURTHER INFORMATION CONTACT: AGENCY: Centers for Disease Control and Service Act. Section 2126, codified at 42
Gregory Anderson, M.S., M.P.H., Prevention (CDC), Department of Health U.S.C. 300aa–26, requires the Secretary
Scientific Review Officer, National and Human Services (HHS). of Health and Human Services to
Center for HIV/AIDS, Viral Hepatitis, ACTION: Notice. develop and disseminate vaccine
STD, and TB Prevention (NCHHSTP), information materials for distribution by
CDC, 1600 Clifton Road NE., Mailstop SUMMARY: Under the National all health care providers in the United
E60, Atlanta, Georgia 30333, Telephone: Childhood Vaccine Injury Act (NCVIA) States to any patient (or to the parent or
(404) 718–8833. (42 U.S.C. 300aa–26), the HHS/CDC legal representative in the case of a
SUPPLEMENTARY INFORMATION: must develop vaccine information child) receiving vaccines covered under
Status: The meeting will be closed to materials that all health care providers the National Vaccine Injury
the public in accordance with are required to give to patients/parents Compensation Program (VICP).
provisions set forth in Section prior to administration of specific Development and revision of the
mstockstill on DSK4VPTVN1PROD with NOTICES

552b(c)(4) and (6), Title 5 U.S.C., and vaccines. On May 20, 2015, CDC vaccine information materials, also
the Determination of the Director, published a notice in the Federal known as Vaccine Information
Management Analysis and Services Register (80 FR 29009) seeking public Statements (VIS), have been delegated
Office, CDC, pursuant to Public Law 92– comments on proposed new vaccine by the Secretary to the Centers for
463. information materials for inactivated Disease Control and Prevention (CDC).
Matters for Discussion: The meeting and live attenuated influenza vaccines. Section 2126 requires that the materials
will include the initial review, Following review of comments be developed, or revised, after notice to
discussion, and evaluation of submitted and consultation as required the public, with a 60-day comment

VerDate Sep<11>2014 18:34 Oct 02, 2015 Jkt 238001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\05OCN1.SGM 05OCN1

Document Created: 2015-12-15 08:52:48
Document Modified: 2015-12-15 08:52:48

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		10:00 a.m.-5:00 p.m., December 9-10, 2015 (Closed).
Contact		Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
FR Citation		80 FR 60149

80 FR 60149 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Initial review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 192 (October 5, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention